Intensive fibrosarcoma-binding capability of the reconstituted analog and its antitumor activity-Reference-Cited by-同舟云学术

Intensive fibrosarcoma-binding capability of the reconstituted analog and its antitumor activity

Published:2017-12-17 Issue:1 Volume:25 Page:102-111
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Xu Jian¹,Du Yue¹,Liu Wen-Juan¹²,Li Liang¹,Li Yi¹,Wang Xiao-Fei¹,Yi Hong-Fei³,Shan Chuan-Kun¹,Xia Gui-Min¹,Liu Xiu-Jun¹,Zhen Yong-Su¹

Affiliation:

1. Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China;

2. Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong Cancer Hospital affiliated to Shandong University Shandong Academy of Medical Sciences, Jinan, China;

3. West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China

Funder

CAMS

Significant New Drug Development’ Major Science and Technology Development

National Key Research and Development

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://tandfonline.com/doi/pdf/10.1080/10717544.2017.1410261

Reference25 articles.

1. Cellular cholesterol regulates MT1 MMP dependent activation of MMP 2 via MEK-1 in HT1080 fibrosarcoma cells

2. High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial

3. Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives

4. Adjuvant Therapy for High-Risk Soft Tissue Sarcoma in the Adult

5. Evaluation of the safety and efficacy of TRAIL and taurolidine use on human fibrosarcoma xenografts in vivo

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of MMP-2 and MMP-9 Gelatinase Blockade as a Therapeutic Strategy in Fibrosarcoma Treatment: A Decadal Review;Targets;2024-06-05

2. Correlation between methylation of the caveolin‐1 gene and of caveolin‐1 messenger ribonucleic acid, and protein levels and human epidermal growth factor receptor 2 protein expression in adenocarcinomas of the esophagogastric junction;Precision Radiation Oncology;2019-02-25

3. CDK11p110 plays a critical role in the tumorigenicity of esophageal squamous cell carcinoma cells and is a potential drug target;Cell Cycle;2019-02-12

4. Enediyne-activated, EGFR-targeted human β-defensin 1 has therapeutic efficacy against non-small cell lung carcinoma;Laboratory Investigation;2018-09-11

5. EGFR-targeting, β-defensin-tailored fusion protein exhibits high therapeutic efficacy against EGFR-expressed human carcinoma via mitochondria-mediated apoptosis;Acta Pharmacologica Sinica;2018-07-16